Q3 2024 saw modest revenue growth but a sharp loss due to major write-downs, with focus shifting to supporting core holdings amid weak microcap market conditions. Financial targets remain unchanged and liquidity is sufficient for the next 12 months.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.